casirivimab
monoclonal antibody against SARS-CoV-2 developed by Regeneron
Press Enter · cited answer in seconds
0 sources
casirivimab
Summary
casirivimab is a monoclonal antibody[1].
Key Facts
- casirivimab's instance of is recorded as monoclonal antibody[2].
- casirivimab's developer is recorded as Regeneron Pharmaceuticals[3].
- casirivimab's CAS Registry Number is recorded as 2415933-42-3[4].
- casirivimab's part of is recorded as casirivimab/imdevimab[5].
- casirivimab's Commons category is recorded as Casirivimab[6].
- casirivimab's UNII is recorded as J0FI6WE1QN[7].
- casirivimab's DrugBank ID is recorded as DB15941[8].
- casirivimab's name is recorded as REGN10933[9].
- casirivimab's Google Knowledge Graph ID is recorded as /g/11mw769k3s[10].
- casirivimab's RxNorm CUI is recorded as 2465242[11].